Trevena, Inc. (NASDAQ:TRVN – Get Free Report) passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.01 and traded as high as $0.0111. Trevena shares last traded at $0.0111, with a volume of 654 shares.
Trevena Stock Up 640.0%
The business’s 50-day moving average is $0.01 and its two-hundred day moving average is $0.01. The company has a market capitalization of $10,644.90, a P/E ratio of -0.00 and a beta of 0.31.
Trevena Company Profile
Trevena, Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of biased ligand G protein-coupled receptor (GPCR) selective medicines. By leveraging its proprietary bias-ligand technology platform, Trevena aims to create therapies that preferentially activate beneficial signaling pathways while minimizing engagement of pathways linked to adverse effects. The company’s research efforts target areas of high unmet medical need, including pain management, cardiometabolic disorders and central nervous system conditions.
The company’s lead compound, oliceridine (also known by its brand name OLINVEO), is a G protein-biased μ-opioid receptor agonist designed for the treatment of moderate to severe acute pain in the hospital setting.
See Also
- Five stocks we like better than Trevena
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Trevena Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trevena and related companies with MarketBeat.com's FREE daily email newsletter.
